Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) Nikkei
38,946.93 -122.75 (-0.31%) Hang Seng
19,220.62 -415.60 (-2.12%) FTSE 100
8,416.45 -7.75 (-0.09%) Bitcoin USD
69,733.21 +1,403.63 (+2.05%) CMC Crypto 200
1,515.41 +26.87 (+1.81%)
Cytokinetics, Incorporated (CYTK)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 01:56PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.35B |
| Enterprise value | 6.49B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 1.59k |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 1.73k |
| Enterprise value/EBITDA | -15.82 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | 55.34% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 110.25 |
| 52-week low 3 | 25.98 |
| 50-day moving average 3 | 66.52 |
| 200-day moving average 3 | 53.59 |
Share statistics
| Avg vol (3-month) 3 | 1.93M |
| Avg vol (10-day) 3 | 1.57M |
| Shares outstanding 5 | 104.85M |
| Implied shares outstanding 6 | 104.85M |
| Float 8 | 104.14M |
| % held by insiders 1 | 0.60% |
| % held by institutions 1 | 114.99% |
| Shares short (30 Apr 2024) 4 | 13.67M |
| Short ratio (30 Apr 2024) 4 | 12.15 |
| Short % of float (30 Apr 2024) 4 | 21.39% |
| Short % of shares outstanding (30 Apr 2024) 4 | 13.07% |
| Shares short (prior month 28 Mar 2024) 4 | 13.23M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:6 |
| Last split date 3 | 25 Jun 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -15,117.96% |
Management effectiveness
| Return on assets (ttm) | -36.66% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 3.75M |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | -81.90% |
| Gross profit (ttm) | N/A |
| EBITDA | -485.59M |
| Net income avi to common (ttm) | -530.6M |
| Diluted EPS (ttm) | -5.40 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 618.96M |
| Total cash per share (mrq) | 5.9 |
| Total debt (mrq) | 754.92M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 7.19 |
| Book value per share (mrq) | -3.78 |
Cash flow statement
| Operating cash flow (ttm) | -421.55M |
| Levered free cash flow (ttm) | -264.91M |
© 2024 Yahoo. All rights reserved.